© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, ADC Therapeutics S.A. (ADCT) shows an Average True Range (ATR) of 0.34 and an Enterprise Value of 241.63M. Its average trading volume over the past 3 months is 1.21M, indicating liquidity. These fundamental metrics provide insight into ADCT's underlying financial health and market activity.
ADC Therapeutics S.A. (ADCT) technical indicators as of December 23, 2025: the SMA 20 is -6.75%, SMA 50 at -9.43%, and SMA 200 at 23.81%. The RSI 14 value is 44.71, suggesting its current momentum. These technical analysis signals help assess ADCT's price trends and potential future movements.
ADC Therapeutics S.A. (ADCT) stock performance overview as of December 23, 2025: The 52-week high is $4.8 (currently -22.92% below), and the 52-week low is $1.05 (currently 252.38% above). Over the past year, ADCT's performance is 85%, compared to the S&P 500's 12.87% change.
According to market data, ADC Therapeutics S.A. (ADCT) stock's recent performance metrics show that over the last month, ADCT is -7.96%, with a Year-to-Date (YTD) performance of 85.93%. Over the past year, the stock has seen a 85% change. These figures summarize ADCT's price movements across various periods, reflecting its historical returns.
According to current financial data, ADCT stock's P/E (TTM) ratio is -3.08, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ADCT, including P/S (5.84), P/B (-2.58), and P/FCF (-3.41), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.